Study number 8539-034
Dates
Apr 02 2025-Jul 24 2025
Location
Dallas, Texas
Age
18-65
Gender
Both Males and Females
Compensation
$15,115
Group
Pt B C1a OR C1b
The investigational drug in this research study is being developed for the treatment of vitiligo, a disease that causes loss of skin color in patches, and related autoimmune disorders. This is the first time that this study drug is being given to humans.
Fortrea Dallas, Tx is recruiting for:
-Healthy Men and Women, age 18-65
-Body Mass Index between 18-32
-Study involves 3 separate stays totaling 12 nights & 10 follow-up visits
-Compensation up to $15,115 may be provided for time and participation
-Refer a friend to receive $350 per qualified referral
*Females must be of nonchildbearing potential
Pt B C1a:
Check-in: Apr 2, 16, 30
Check-out: Apr 9, 18, May 3
Follow-up: Apr 13, 23, May 7, 11, 15, 29, Jun 12, 26, Jul 10, 24
Pt B C1b:
Check-in: Apr 3, 17, May 1
Check-out: Apr 10, 19, May 4
Follow-up: Apr 14, 24, May 8, 12, 16, 30, Jun 13, 27, Jul 11, 25,